CA2099497A1 - Peptides possedant une activite anticoagulante - Google Patents

Peptides possedant une activite anticoagulante

Info

Publication number
CA2099497A1
CA2099497A1 CA002099497A CA2099497A CA2099497A1 CA 2099497 A1 CA2099497 A1 CA 2099497A1 CA 002099497 A CA002099497 A CA 002099497A CA 2099497 A CA2099497 A CA 2099497A CA 2099497 A1 CA2099497 A1 CA 2099497A1
Authority
CA
Canada
Prior art keywords
peptides
anticoagulant activity
scription
formula
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002099497A
Other languages
English (en)
Other versions
CA2099497C (fr
Inventor
Bernhard Schmied
Hans W. Hoeffken
Wilfried Hornberger
Harald Bernard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott GmbH and Co KG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2099497A1 publication Critical patent/CA2099497A1/fr
Application granted granted Critical
Publication of CA2099497C publication Critical patent/CA2099497C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CA002099497A 1991-02-07 1991-11-21 Peptides possedant une activite anticoagulante Expired - Fee Related CA2099497C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4103649A DE4103649A1 (de) 1991-02-07 1991-02-07 Neue antikoagulatorisch wirksame peptide
DEP4103649.2 1991-02-07
PCT/EP1991/002191 WO1992013879A1 (fr) 1991-02-07 1991-11-21 Nouveaux peptides a activite anticoagulante

Publications (2)

Publication Number Publication Date
CA2099497A1 true CA2099497A1 (fr) 1992-08-08
CA2099497C CA2099497C (fr) 2001-12-25

Family

ID=6424532

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002099497A Expired - Fee Related CA2099497C (fr) 1991-02-07 1991-11-21 Peptides possedant une activite anticoagulante

Country Status (10)

Country Link
US (1) US5393873A (fr)
EP (1) EP0570375B1 (fr)
JP (1) JP3315690B2 (fr)
AT (1) ATE121422T1 (fr)
CA (1) CA2099497C (fr)
DE (2) DE4103649A1 (fr)
DK (1) DK0570375T3 (fr)
ES (1) ES2071343T3 (fr)
MX (1) MX9203516A (fr)
WO (1) WO1992013879A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230252B1 (hu) * 2001-01-12 2015-11-30 Biogen Idec International Gmbh Fumársav-amid származékok
EP1425296B1 (fr) * 2001-09-10 2011-04-13 Novel Science International GmbH Composes organiques a activite biologique utilises comme inhibiteurs de thrombine et leur utilisation
DK1737889T3 (da) 2004-10-19 2011-01-03 Lonza Ag Fremgangsmåde til fastfase-peptidsyntese
CN101033249B (zh) * 2006-03-10 2011-05-11 周逸明 固相多肽合成比筏芦定的制备方法
US8501241B1 (en) 2012-09-17 2013-08-06 Biopep Solutions, Inc. Treating cancer with a whole, leech saliva extract
CN103408459B (zh) * 2013-08-21 2014-10-08 中国药科大学 4-氰基苯丙氨酸的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (fr) * 1987-01-23 2000-06-20 John L. Krstenansky Peptides anti-coagulants
ZA883444B (fr) * 1987-05-21 1988-11-16
HUT55799A (en) * 1988-09-29 1991-06-28 Biogen Inc Process for producing hirudine-like peptides
WO1990006128A1 (fr) * 1988-12-05 1990-06-14 Biogen, Inc. Methodes et compositions pour inhiber l'agregation des plaquettes
AU630132B2 (en) * 1988-12-07 1992-10-22 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
CA2064195A1 (fr) * 1989-07-20 1991-01-21 John M. Maraganore Derives de peptide et d'hirudine
AU641215B2 (en) * 1990-02-13 1993-09-16 Merrell Dow Pharmaceuticals Inc. Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin
DE4005591A1 (de) * 1990-02-22 1991-09-05 Behringwerke Ag Die blutgerinnung inhibierende peptide, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
DK0570375T3 (da) 1995-07-03
DE4103649A1 (de) 1992-08-13
JP3315690B2 (ja) 2002-08-19
ATE121422T1 (de) 1995-05-15
EP0570375B1 (fr) 1995-04-19
ES2071343T3 (es) 1995-06-16
US5393873A (en) 1995-02-28
JPH06504989A (ja) 1994-06-09
CA2099497C (fr) 2001-12-25
EP0570375A1 (fr) 1993-11-24
DE59105281D1 (de) 1995-05-24
WO1992013879A1 (fr) 1992-08-20
MX9203516A (es) 1992-08-31

Similar Documents

Publication Publication Date Title
CA2123051A1 (fr) Derives d'acides nor-biliaires, methodes pour les preparer et utilisation de ces composes a titre de medicaments
CA2201785A1 (fr) Nouveaux derives d'acide carboxylique, leur preparation et leur utilisation
IT1211468B (it) Alfa aril alfa feniletil 1h 1 24 triazolo 1 propanonitrili procedimento per la loro preparazione e impiego come fungicidi
CA2105304A1 (fr) Inhibiteurs de l'elastase de neutrophile humaine et de la cathepsin g humaine
AU7702291A (en) Dietary fiber, its process and physiologically active composition containing the same as an active ingredient
CA2230819A1 (fr) Medicament comprenant le gene hgf
CA2079342A1 (fr) Composes pharmaceutiques multifonctionnels, leur methode de fabrication et leurs utilisations
HUT63374A (en) Process for producing new benzoic acid derivatives having cardiovascular activity and pharmaceutical compositions comprising such active ingredient
CA2114313A1 (fr) Peptides bpc, leur preparation et utilisation
HUT44908A (en) Fungicides comprising triazolyl- or imidazolyl-group-substituted 2,5-dihydrofuran derivatives as active ingredient and process for producing the active ingredient and intermediaries thereof
AU8757891A (en) Photo-labile compounds, their synthesis and use as fluorophores
CA2097044A1 (fr) Acides a groupement cyclopentane- et pentene-.beta.-amino
IT8521468A0 (it) Procedimento per ottenere interferon leucocitario alfa-2dell'uomo.
CA2071907A1 (fr) Proteines bcrf1 utilisees comme inhibiteurs de l'interferon-a
CA2094275A1 (fr) Methodes et compositions pour le traitement de maladies cytoproliferatives
CA2099497A1 (fr) Peptides possedant une activite anticoagulante
IL99495A0 (en) Fungicidally active compounds,their production and their use as fungicides
CA2263846A1 (fr) Nouveaux derives de pyranoside
IT1222840B (it) Struttura di valvola cardiaca artificiale ad elevato rendimento
MY114693A (en) Substituted benzenesulfonylureas and thioureas,processes for their preparation,their use for the production of pharmaceutical preparations, and pharmaceutical preparation containing them
CA2075926A1 (fr) Esters d'acides amines et d'hydroquinone, methodes d'obtention et compositions phramaceutiques ou cosmetiques qui en contiennent
EP0390181A3 (fr) Dérivés de pérylène quinones (UCN-1028D)
EP0492478A3 (en) Tert-butyloxycarbonyl-l-tyrosyl-peptidoglycan monomer and 125 i-labelled derivative thereof, their preparation and use
EP0362152A3 (fr) Emploi de l'acide 3-indolepyruvique comme agent pharmaceutique pour inhiber les pathologies dégénératives périphériques
DE3878988D1 (de) 1,2-di(4-isobutylphenyl)aethylen, dessen herstellung und verwendung als zwischenprodukt.

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed